Transdermal testosterone

DRUG3 trials

Sponsors

Hospital Clinic of Barcelona, University of Colorado, Denver, University of Sao Paulo General Hospital

Conditions

Castration-Resistant Prostate CancerFemale Sexual DysfunctionOvarian ResponsePostmenopausal SymptomsProstate CancerTestosterone Adverse ReactionTestosterone Deficiency

Early Phase 1

Testosterone Therapy in Castration Resistant Prostate Cancer

CompletedNCT03734653

University of Colorado, DenverCastration-Resistant Prostate Cancer, Prostate Cancer

Start: 2019-01-18End: 2025-09-30Updated: 2025-11-06

Phase 2

Sexual Effects of Transdermal or Vaginal Testosterone

Active, not recruitingNCT06794346

University of Sao Paulo General HospitalFemale Sexual Dysfunction, Postmenopausal Symptoms, Testosterone Adverse Reaction +1

Start: 2020-10-01End: 2025-11-01Target: 132Updated: 2025-01-27

Phase 3

Androgens for Poor Responders in In Vitro Fertilization

CompletedNCT00693108

Hospital Clinic of BarcelonaOvarian Response

Start: 2006-09-30Updated: 2008-06-06

Related Papers

Transdermal square-wave testosterone therapy: A pilot trial in metastatic castration-resistant prostate cancer.

Journal of Clinical Oncology2023-02-20